| Turkey | Vienna | Spain | |
| Immunotherapy | from $3,000 | ≈ $6,000 | from $4,000 |
| Sarcoma Immunotherapy | from $8,900 | ≈ $18,000 | from $6,200 |
| Immunotherapy for prostate cancer | from $8,000 | ≈ $9,000 | from $6,200 |
| Immunotherapy for lung cancer | from $8,000 | ≈ $9,500 | from $5,000 |
| Immunotherapy for kidney cancer | from $8,000 | ≈ $14,000 | from $2,200 |
No hidden fees – just official clinic prices. Pay at the clinic for Immunotherapy upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy journey.
Day 1
Day 2
Day 3
Day 4
Day 5 to Day 7
Week 2
Week 3
Week 4
Please note that each patient"s case is unique and the above schedule can change depending on the patient"s health condition and response to the treatment.
Prof. Christoph Zielinski is a global leader in immunotherapy with 44 years shaping modern cancer care. He integrates cutting-edge research with personalized patient treatments.
Univ. Prof. Dr. Wolfgang Köstler is a leading expert in breast cancer and gynecologic malignancies, with over 22 years of experience in targeted cancer therapies at Wiener Privatklinik.
Assoc. Prof. Priv.-Doz. Dr. Alexander W. Hauswirth is a specialist in internal medicine and haemato‑oncology at JUVENIS. Since 2010, he has served as the lead senior physician for Haematology/Haemostaseology and Oncology at the Clinic for Internal Medicine I, Medical University of Vienna/AKH Vienna, Austria’s largest hospital.
He earned his medical degree from the University of Vienna in 1999. He received the venia docendi in 2010 and was appointed Associate Professor in 2012. He completed an additional haemato‑oncology qualification in 2014. As a Schrödinger Fellow in Salamanca in 2009–2010, he researched CLL stem and precursor cells. He has published regularly since 2000.
Accreditations include Austrian Medical Chamber diplomas in emergency medicine (since 2009) and sports medicine (2018). Awards include the Schrödinger Fellowship (2009), the ÖGHO award (2009), and the European Society of Chemotherapy poster award (2003). Clinical focus: anaemias, leukaemias, lymph node disorders, clotting and anticoagulation, and pre‑operative clearance. Languages: German and English.
Written by Kateryna Zamkovska